Author

Hiroyuki Seimiya

Japanese Foundation For Cancer ResearchORCID 0000-0003-3314-9736Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Hui JiangiD· 1 shared Kaori Igarashi· 1 shared Kaori SaitohiD· 1 shared Keiko KatoiD· 1 shared Kiyonaga Fujii· 1 shared Kotaro MatobaiD· 1 shared Masahiro SonoshitaiD· 1 shared Matthias MackiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Hui JiangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 23, 2024

Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer

Takako Ooshio, Yusuke Satoh, Hui Jiang…·Masahiro Sonoshita

The paper identifies dual targeting of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer by showing synergistic suppression of PDAC xenograft growth.

1 citation

humanDrosophila

𝕏 PostBluesky